Literature DB >> 12752348

Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study.

G D Eslick1, M P Jones, N J Talley.   

Abstract

BACKGROUND: Little is known about the prevalence and importance of non-cardiac chest pain in the general population. AIM: To evaluate the magnitude and impact of this condition.
METHODS: A validated self-report questionnaire was mailed to a sample of 1000 residents of Penrith, selected randomly from the electoral rolls. Symptoms, risk factors, psychological distress, quality of life and demographics were measured.
RESULTS: The response rate was 73% (n = 672; mean age, 46 years; 52% female). Chest pain ever was reported by 39% of the population; 7% reported a history of myocardial infarction and 8% a history of angina. Two hundred and nineteen (33%) cases were classified as non-cardiac chest pain; only 23% had consulted a physician about chest pain in the previous year. The only independent risk factor for non-cardiac chest pain was the frequency of heartburn (odds ratio, 1.74; 95% confidence interval, 1.08-2.79; P = 0.02). None of the gastrointestinal (heartburn, dysphagia, acid regurgitation) or psychological (anxiety, depression, neuroticism) risk factors were significantly associated with consulting for non-cardiac chest pain.
CONCLUSIONS: Non-cardiac chest pain is remarkably common in the general population and negatively impacts on the quality of life. Gastro-oesophageal reflux disease is a key risk factor for non-cardiac chest pain in the community. Health care seeking for non-cardiac chest pain remains unexplained.

Entities:  

Mesh:

Year:  2003        PMID: 12752348     DOI: 10.1046/j.1365-2036.2003.01557.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  62 in total

1.  Management of esophageal chest pain.

Authors:  Sami R Achem
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-10

2.  Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain.

Authors:  Guy D Eslick; Ronnie Fass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

3.  Ultrasonographic study of mechanosensory properties in human esophagus during mechanical distension.

Authors:  Ejnar Larsen; Hariprasad Reddy; Asbjorn Mohr Drewes; Lars Arendt-Nielsen; Hans Gregersen
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  Evaluation of noncardiac chest pain in Indian setting--can we reduce the investigation burden?

Authors:  Mayank Jain
Journal:  Indian J Gastroenterol       Date:  2015-05

5.  Identifying and managing functional cardiac symptoms.

Authors:  Jonathan Rogers; George Collins; Mujtaba Husain; Mary Docherty
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 6.  Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause?

Authors:  Nigel Flook; Peter Unge; Lars Agréus; Björn W Karlson; Staffan Nilsson
Journal:  Can Fam Physician       Date:  2007-02       Impact factor: 3.275

7.  Clinical distinct features of noncardiac chest pain in young patients.

Authors:  Tae Ho Seo; Jeong Hwan Kim; Jung Hyeon Lee; Soon Young Ko; Sung Noh Hong; In-Kyung Sung; Hyung Seok Park; Chan Sub Shim
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

8.  Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins.

Authors:  Helena Nordenstedt; Zongli Zheng; Alan J Cameron; Weimin Ye; Nancy L Pedersen; Jesper Lagergren
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

9.  Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality.

Authors:  Ana Ruigómez; Elvira L Massó-González; Saga Johansson; Mari-Ann Wallander; Luis A García-Rodríguez
Journal:  Br J Gen Pract       Date:  2009-03       Impact factor: 5.386

10.  A Review of Esophageal Chest Pain.

Authors:  Enrique Coss-Adame; Satish S C Rao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.